| 1 |
24830305 | Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients. | 2014 Nov |
2 |
| 2 |
24068825 | Short-term quetiapine treatment alters the use of reinforcement signals during risky decision-making and promotes the choice of negative expected values in healthy adult males. | 2013 Sep 25 |
1 |
| 3 |
22037407 | Quetiapine improves response inhibition in alcohol dependent patients: a placebo-controlled pilot study. | 2012 Jan |
1 |
| 4 |
22419526 | Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease. | 2012 May |
1 |
| 5 |
22519923 | Quetiapine: a review of its use in the management of bipolar depression. | 2012 May 1 |
1 |
| 6 |
20614105 | Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine. | 2011 Feb |
2 |
| 7 |
21487653 | A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving. | 2011 Oct |
1 |
| 8 |
20887583 | Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature. | 2010 Sep |
1 |
| 9 |
18224291 | Manic symptoms probably associated with short-term low-dose quetiapine use. | 2008 Jan |
1 |
| 10 |
17563257 | A preclinical and clinical rationale for quetiapine in mood syndromes. | 2007 Jun |
1 |
| 11 |
19300555 | Quetiapine in the treatment of schizophrenia and related disorders. | 2007 Apr |
1 |
| 12 |
16855458 | Quetiapine-induced obsessive-compulsive symptoms: a series of five cases. | 2006 Aug |
1 |
| 13 |
12397853 | Antipsychotic-induced hyperprolactinemia and sexual dysfunction. | 2002 Winter |
1 |
| 14 |
11313155 | D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study. | 2001 Apr |
2 |
| 15 |
11512044 | In vivo 5-HT2A receptor blockade by quetiapine: an R91150 single photon emission tomography study. | 2001 Aug |
4 |
| 16 |
9497016 | Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia. | 1998 Jan |
1 |